In mixed/cholestatic immune-related liver injury, what triggers you to add or switch from corticosteroids to non-steroid immunosuppression—histology (e.g., acute cholangitis or multi-duct injury) versus predefined biochemical non-response—and how do you handle this when early steroids may blunt the diagnostic yield of biopsy?